Literature DB >> 12830454

Serum cystatin C in the aged: relationships with health status.

Elise Wasén1, Raimo Isoaho, Kari Mattila, Tero Vahlberg, Sirkka-Liisa Kivelä, Kerttu Irjala.   

Abstract

BACKGROUND: Serum cystatin C (Cys C) is claimed to be superior to serum creatinine (Cr) in estimating glomerular filtration rate, but its utility in assessing renal function in the polymorbid elderly needs to be evaluated.
METHODS: In a cross-sectional, community-based survey performed in Lieto in southwestern Finland, Cys C, Cr, and urinary albumin-creatinine ratio (ACR) were measured in 1,260 subjects aged 64 to 100 years. Associations of demographic characteristics and health status factors with levels of Cys C, Cr, and ACR were assessed by means of linear models.
RESULTS: In men, hypertension, coronary heart disease, urinary infection, rheumatoid arthritis, glucocorticoid treatment, older age, and lower functional status were found to be significant predictors of higher Cys C values, whereas hypertension, coronary heart disease, urinary infection, older age, and increasing body mass index (BMI) significantly predicted higher Cr values. Among women, corresponding factors were hypertension, glucocorticoid treatment, age, functional status, and BMI for Cys C and hypertension, BMI, and age for Cr. Diabetes was significantly associated only with ACR. These factors explained 35% of variation in Cys C values in men and 34.5% in women versus only 14.8% and 11.3% for Cr, respectively.
CONCLUSION: Glucocorticoid treatment was recognized as an independent Cys C-increasing factor, presumably nonglomerular. In comparison with Cys C, a considerably greater proportion of total variation in Cr values seems to be explained by extrarenal factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12830454     DOI: 10.1016/s0272-6386(03)00406-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  22 in total

1.  Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.

Authors:  R J Macisaac; C Tsalamandris; M C Thomas; E Premaratne; S Panagiotopoulos; T J Smith; A Poon; M A Jenkins; S I Ratnaike; D A Power; G Jerums
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

2.  Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.

Authors:  Fabienne Thomas; Sophie Séronie-Vivien; Laurence Gladieff; Florence Dalenc; Valérie Durrand; Laurence Malard; Thierry Lafont; Muriel Poublanc; Roland Bugat; Etienne Chatelut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  GFR is better estimated by considering both serum cystatin C and creatinine levels.

Authors:  Yann Bouvet; François Bouissou; Yvon Coulais; Sophie Séronie-Vivien; Mathieu Tafani; Stéphane Decramer; Etienne Chatelut
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

4.  Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease.

Authors:  Mark Mitsnefes; Thomas Kimbal; Janis Kartal; Thelma Kathman; Jaya Mishra; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

Review 5.  Measurement of renal function in patients with chronic kidney disease.

Authors:  Euan A Sandilands; Neeraj Dhaun; James W Dear; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 6.  Cystatin C, kidney function and cardiovascular disease.

Authors:  Arend Bökenkamp; Stefan Herget-Rosenthal; Regina Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

7.  The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population.

Authors:  Angelos A Evangelopoulos; Natalia G Vallianou; Vassiliki P Bountziouka; Amalia N Giotopoulou; Maria S Bonou; John Barbetseas; Peter C Avgerinos; Demosthenes B Panagiotakos
Journal:  Cardiol Res Pract       Date:  2010-10-14       Impact factor: 1.866

8.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

9.  Comparison of glomerular function tests in children with cancer.

Authors:  Marika H Grönroos; Timo Jahnukainen; Kerttu Irjala; Risto Härkönen; Saija Hurme; Merja Möttönen; Toivo T Salmi
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

10.  Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study).

Authors:  Nisha I Parikh; Shih-Jen Hwang; Qiong Yang; Martin G Larson; Chao-Yu Guo; Sander J Robins; Patrice Sutherland; Emelia J Benjamin; Daniel Levy; Caroline S Fox
Journal:  Am J Cardiol       Date:  2008-09-12       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.